title: Putative cocaine receptor in striatum is a glycoprotein with active thiol function.
abstract: Dopamine transporters of bovine and rat striata were identified by their specific [3H]cocaine binding and cocaine-sensitive [3H]dopamine [( 3H]DA) uptake. Both binding and uptake functions of bovine striatal transporters were potentiated by lectins. Concanavalin A (Con A) increased the velocity but did not change the affinity of the transporter for DA; however, it increased its affinity for cocaine without changing the number of binding sites. This suggests that the DA transporter is a glycoprotein and that Con A action on it produces conformational changes. Inorganic and organic mercury reagents inhibited both [3H]DA uptake and [3H]cocaine binding, though they were all more potent inhibitors of the former. n-Ethylmaleimide inhibited [3H]DA uptake totally but [3H]cocaine binding only partially. Also, n-pyrene maleimide had differential effects on uptake and binding, inhibiting uptake and potentiating binding. [3H]DA uptake was not affected by mercaptoethanol up to 100 mM, whereas [3H]cocaine binding was inhibited by concentrations above 10 mM. On the other hand, both uptake and binding were fairly sensitive to dimercaprol (less than 1 mM). The effects of all these sulfhydryl reagents suggest that the DA transporter has one or more thiol group(s) important for both binding and uptake activities. The Ellman reagent and dithiopyridine were effective inhibitors of uptake and binding only at fairly high concentration (greater than 10 mM). Loss of activity after treatment with the dithio reagents may be a result of reduction of a disulfide bond, which may affect the transporter conformation.
authors.affiliation: Department of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, Baltimore 21201.
authors.forename: C J
authors.initials: CJ
authors.lastname: Cao
authors.forename: M M
authors.initials: MM
authors.lastname: Young
authors.forename: J B
authors.initials: JB
authors.lastname: Wong
authors.forename: L G
authors.initials: LG
authors.lastname: Mahran
authors.forename: M E
authors.initials: ME
authors.lastname: Eldefrawi
mesh_terms: D002731:4-Chloromercuribenzenesulfonate / Q000494:pharmacology; D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D002352:Carrier Proteins; D002417:Cattle; D003042:Cocaine / Q000378:metabolism / Q000494:pharmacology; D003208:Concanavalin A / Q000494:pharmacology; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism; D006023:Glycoproteins / Q000378:metabolism*; D007700:Kinetics; D037102:Lectins / Q000494:pharmacology; D008297:Male; D008301:Maleimides / Q000494:pharmacology; D008627:Mercuric Chloride / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D011955:Receptors, Drug / Q000378:metabolism*; D013438:Sulfhydryl Compounds / Q000378:metabolism*; D013439:Sulfhydryl Reagents / Q000494:pharmacology; D013574:Synaptosomes / Q000378:metabolism
chemical_list: D002352:Carrier Proteins; D006023:Glycoproteins; D037102:Lectins; D008301:Maleimides; D011955:Receptors, Drug; D013438:Sulfhydryl Compounds; D013439:Sulfhydryl Reagents; C061445:cocaine receptor; D003208:Concanavalin A; D008627:Mercuric Chloride; D002731:4-Chloromercuribenzenesulfonate; D003042:Cocaine; D004298:Dopamine